Clifton Park Capital Management’s Pediatrix Medical MD Stock Holding History

Clifton Park Capital Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$290M	Buy	4,053,000 +200,000	+5%	+$14.8M	32.99%	1
2015 Q3	$296M	Hold	3,853,000	–	–	26.47%	1
2015 Q2	$286M	Sell	3,853,000 -3,841	-0.1%	-$276K	20.8%	1
2015 Q1	$280M	Sell	3,856,841 -484,853	-11%	-$33.7M	17.02%	2
2014 Q4	$287M	Buy	4,341,694 +103,000	+2%	+$6.29M	17.03%	1
2014 Q3	$232M	Sell	4,238,694 -130,000	-3%	-$7.38M	16.64%	1
2014 Q2	$254M	Sell	4,368,694 -91,306	-2%	-$5.37M	16.28%	2
2014 Q1	$276M	Hold	4,460,000	–	–	17.1%	1
2013 Q4	$238M	Hold	4,460,000	–	–	13.74%	2
2013 Q3	$224M	Hold	4,460,000	–	–	13.29%	1
2013 Q2	$204M	Buy	+4,460,000	New	+$200M	12.12%	1

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Clifton Park Capital Management's MD Position: Q4 2015 in Review

Clifton Park Capital Management increased its Pediatrix Medical (MD) stake by 5.2% in Q4 2015, buying an estimated $14.8M and bringing the position to 4,053,000 shares worth $290M. The position accounts for 32.99% of the portfolio, ranked #1.

Clifton Park Capital Management first reported a position in MD in Q2 2013 and has held it in 11 quarters since. The position peaked at $296M in Q3 2015. 399 funds tracked by Wall St. Rank hold MD as of Q4 2015.

Clifton Park Capital Management held 4,053,000 shares of Pediatrix Medical worth $290M as of Q4 2015.
Clifton Park Capital Management bought 200,000 Pediatrix Medical shares in Q4 2015, an estimated $14.8M.
Pediatrix Medical made up 32.99% of Clifton Park Capital Management's portfolio in Q4 2015, its #1 holding.
Clifton Park Capital Management first reported a position in Pediatrix Medical in Q2 2013 and has held it in 11 quarters since.
Clifton Park Capital Management's Pediatrix Medical position peaked at $296M in Q3 2015.
399 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2015.

Based on Clifton Park Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.